Suman Paul, MBBS, PhD

Suman Paul practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Suman Paul's NPI, 1003253360, was assigned on May 28, 2013. Suman Paul holds Maryland license D83037.

Suman Paul's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Suman Paul's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Suman Paul is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Suman Paul to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Suman Paul practices. Vendor and product names are available with a free account.

Medical oncology is Suman Paul's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Suman Paul is board certified in internal medicine by the American Board of Internal Medicine. Suman Paul is licensed in Maryland.

CMS data shows 80 Medicare services from Suman Paul across 2 procedure codes in 2024, for 32 Medicare patients. Medicare paid $8,614 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 32 Medicare patients who saw Suman Paul in 2024. 75% of them have high blood pressure, and 69% have high cholesterol. Their average risk score is 2.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Suman Paul's median patient age at 68, with 46% women.

In 2021, Suman Paul wrote 11 Medicare Part D claims. They cover 1 drug, with $359 in total drug cost. In 2016, CMS named 133 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Suman Paul for performance year 2024, reported as part of a group.

Dmand AI links 40 papers to Suman Paul, published from 2011 to 2025. 2024 was the busiest year, with 8. The most frequent topics are T-Lymphocytes, Antibodies, Bispecific and Antigens, Neoplasm. Suman Paul has published most often in Nat Commun. Suman Paul's most frequent co-authors are Chetan Bettegowda, MD, PhD, Maximilian Konig, MD and Ephraim Joseph Fuchs, MD.

CMS Open Payments shows 16 general payments to Suman Paul from 1 drug or device company in 2024. Consulting fees make up the largest share, 81% of the total. Merck Sharp & Dohme Corporation paid the most, $12,082.